Cognitive Impairment Associated with Schizophrenia: a Review of the Humanistic Burden

被引:55
|
作者
Kitchen, Helen [1 ]
Rofail, Diana
Heron, Louise
Sacco, Pat [2 ]
机构
[1] Adelphi Mill, Adelphi Values, Bollington SK10 5JB, Cheshire, England
[2] Novartis Pharmaceut, E Hanover, NJ USA
关键词
burden; cognitive impairment associated with schizophrenia; conceptual model; cost; humanistic; patient reported outcome; schizophrenia; QUALITY-OF-LIFE; ANTIPSYCHOTIC MEDICATIONS; 2ND-GENERATION ANTIPSYCHOTICS; CONVENTIONAL ANTIPSYCHOTICS; 1ST-EPISODE SCHIZOPHRENIA; ATYPICAL ANTIPSYCHOTICS; EXECUTIVE FUNCTION; NEGATIVE SYMPTOMS; ECONOMIC BURDEN; UNITED-STATES;
D O I
10.1007/s12325-012-0001-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Nearly every individual with schizophrenia is affected by cognitive decline. The aim of this literature review was to: (a) describe the humanistic burden of cognitive impairment associated with schizophrenia (CIAS); (b) develop a conceptual model that depicts the signs and symptoms of CIAS along with key concepts important to patients; and (c) consider the adequacy of potential patient-reported outcome (PRO) instruments for assessing future treatments. Methods: The following electronic databases were searched for articles published between January 1999 and November 2009 related to CIAS and PROs, or cost of illness: Medline; Embase; PsycINFO; the Health Economic Evaluation Database; and the National Health Service Economic Evaluation Database and Health Technology Assessment databases at the Centre for Reviews and Dissemination, University of York. Results: The literature search revealed 3950 abstracts, of which 101 articles were reviewed in detail. Cognitive functions affected include memory, attention/concentration, problem solving, learning, executive function, processing speed, and social cognition. Cognitive impairment impacts the ability of individuals to carry out activities of daily living, work productively, function socially, and adhere to treatment. These effects have economic ramifications through increased direct and indirect costs associated with the treatment of schizophrenia. The literature revealed 39 PRO instruments that have been used to assess functioning. However, no single instrument captures all key concepts of importance to patients with schizophrenia. Conclusion: The significant burden from CIAS for patients and society has implications for designing future treatments and health strategies to improve functional outcomes.
引用
收藏
页码:148 / 162
页数:15
相关论文
共 50 条
  • [1] Cognitive Impairment Associated with Schizophrenia: A Review of the Humanistic Burden
    Helen Kitchen
    Diana Rofail
    Louise Heron
    Pat Sacco
    Advances in Therapy, 2012, 29 : 148 - 162
  • [2] Humanistic burden in schizophrenia: A literature review
    Millier, A.
    Schmidt, U.
    Angermeyer, M. C.
    Chauhan, D.
    Murthy, V.
    Toumi, M.
    Cadi-Soussi, N.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 54 : 85 - 93
  • [3] Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review
    Zoupa, Elli
    Bogiatzidou, Olympia
    Siokas, Vasileios
    Liampas, Ioannis
    Tzeferakos, Georgios
    Mavreas, Venetsanos
    Stylianidis, Stelios
    Dardiotis, Efthimios
    NEUROLOGY INTERNATIONAL, 2023, 15 (01): : 12 - 23
  • [4] B-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review
    Chung, Jun Ku
    Nakajima, Shinichiro
    Plitman, Eric
    Iwata, Yusuke
    Uy, Danielle
    Gerretsen, Philip
    Caravaggio, Fernando
    Chakravarty, M. Mallar
    Graff-Guerrero, Ariel
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 24 (10) : 923 - 939
  • [5] Is quality of life associated with cognitive impairment in schizophrenia?
    Alptekin, K
    Akvardar, Y
    Akdede, BBK
    Dumlu, K
    Isik, D
    Pirinçci, F
    Yahssin, S
    Kitis, A
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (02) : 239 - 244
  • [6] Antidepressants for cognitive impairment in schizophrenia - A systematic review and meta-analysis
    Vernon, Jeffrey A.
    Grudnikoff, Eugene
    Seidman, Andrew J.
    Frazier, Thomas W.
    Vemulapalli, Mani Sandhya
    Pareek, Priyanki
    Goldberg, Terry E.
    Kane, John M.
    Correll, Christoph U.
    SCHIZOPHRENIA RESEARCH, 2014, 159 (2-3) : 385 - 394
  • [7] The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia
    Cotter, Jack
    Barnett, Jennifer H.
    Granger, Kiri
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [8] The humanistic and economic burden of providing care for a patient with schizophrenia
    Csoboth, Csilla
    Witt, Edward A.
    Villa, Kathleen F.
    O'Gorman, Cedric
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2015, 61 (08) : 754 - 761
  • [9] Psychiatric and functional correlates of stigma associated with cognitive impairment in schizophrenia
    Gonzales, Lauren
    Saperstein, Alice M.
    Qian, Min
    Gorecki, Adam
    Medalia, Alice
    PSYCHIATRY RESEARCH, 2024, 342
  • [10] The awareness, characterization, and burden of Cognitive Impairment Associated with Schizophrenia (CIAS) in clinical practice: Results from a nationwide survey in Italy
    Vita, Antonio
    Barlati, Stefano
    Cavallaro, Roberto
    Cipelli, Riccardo
    Corrivetti, Giulio
    Delmonte, Dario
    Lusito, Eleonora
    Maia, Elisabetta
    Marino, Maria Michela
    Nicolo, Giuseppe
    Rocca, Paola
    Galderisi, Silvana
    SCHIZOPHRENIA RESEARCH-COGNITION, 2025, 40